Disclaimer: Intended For Medical Professionals Only
AjantaMed Dialogue
Stay Informed, Stay Ahead
Latest News :
New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management • New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management •
sticky-medbot
Resimed 145 | Epidermolysis Bullosa (Part 02)

Resimed 145 | Epidermolysis Bullosa (Part 02)

Resimed 145 (Part 02) continues the in-depth discussion on Epidermolysis Bullosa (EB), a group of inherited blistering disorders characterized by extreme skin fragility.

 

This session delves deeper into:

Classification and subtypes of Epidermolysis Bullosa

Diagnostic approach and confirmatory investigations

Role of histopathology, immunofluorescence, and genetic testing

Clinical implications for long-term management and patient care

 

An essential continuation for dermatologists, pediatricians, pathologists and postgraduate students seeking a structured understanding of EB beyond clinical presentation.

By : Dr. Grurdatta Baraka; Dr. Manoj Srinivasa

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.